Clinical Trial Update: Effects of DES Platforms on Markers of Endothelial Damage and Inflammation [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluating how different drug-eluting stent platforms influence markers of endothelial damage and inflammation in coronary arter…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Drug-eluting stents

Snippet

Sponsor: University of Roma La Sapienza | Conditions: Coronary Artery Disease | Phase 4 | Status: UNKNOWN